Uncategorized
Regeneron reports 46% increase in total revenue for year
Regeneron reported a year-end total revenue of $4.1 billion for 2015 compared with $2.8 billion in 2014, according to a company press release. The 46% increase was partially attributed to an increase in the company’s net profit from commercialization of Eylea (aflibercept, Regeneron) outside of the United States.